Cite
HARVARD Citation
Santagostino, E. et al. (n.d.). Daclatasvir/peginterferon lambda‐1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa‐2a/ribavirin. Haemophilia. pp. 692-699. [Online].